These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31726287)

  • 1. Initial assessment of an interprofessional team-delivered telehealth program for patients with epilepsy.
    Axon DR; Taylor AM; Vo D; Bingham J
    Epilepsy Res; 2019 Dec; 158():106235. PubMed ID: 31726287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating Innovative Telehealth Solutions into an Interprofessional Team-Delivered Chronic Care Management Pilot Program.
    Taylor AM; Bingham J; Schussel K; Axon DR; Dickman DJ; Boesen K; Martin R; Warholak TL
    J Manag Care Spec Pharm; 2018 Aug; 24(8):813-818. PubMed ID: 30058982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Effect of a Telepharmacist's Recommendations During an Integrated, Interprofessional Telehealth Appointment and Their Alignment with Quality Measures.
    Tetuan C; Axon DR; Bingham J; Boesen K; Lipsy R; Scovis N; Taylor AM; Warholak T; Lott BE; Leal S
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1334-1339. PubMed ID: 31778622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a Pharmacist-Led Telephonic Medication Therapy Management Program in Rural Arizona: Implications for Community Health Practice.
    Axon DR; Kloster J; Eckert B; Morales S; Riggs S; Kilungo A; Ehiri J; Grieser M; Turner-Warren T; Aseret-Manygoats T; Bingham JM; Scovis N; Warholak T
    Clin Pract; 2022 Apr; 12(3):243-252. PubMed ID: 35645306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy problems and medication discrepancies during care transitions in super-utilizers.
    Surbhi S; Munshi KD; Bell PC; Bailey JE
    J Am Pharm Assoc (2003); 2016; 56(6):633-642.e1. PubMed ID: 27720595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge of epilepsy among German pharmacists.
    Müller RM; Herziger B; Jeschke S; Neininger MP; Bertsche T; Bertsche A
    Epilepsy Res; 2021 May; 172():106587. PubMed ID: 33647738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing medication use with a pharmacist-provided comprehensive medication management service for patients with psychiatric disorders.
    Cobb CD
    Pharmacotherapy; 2014 Dec; 34(12):1336-40. PubMed ID: 25329409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy.
    Doucette WR; McDonough RP; Klepser D; McCarthy R
    Clin Ther; 2005 Jul; 27(7):1104-11. PubMed ID: 16154490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of an older adult epilepsy clinic utilizing pharmacist services.
    Marawar R; Faraj M; Lucas K; Burns CV; Garwood CL
    J Am Pharm Assoc (2003); 2021; 61(6):e93-e98. PubMed ID: 34330650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
    Stephen LJ; Wishart A; Brodie MJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication treatment for attention-deficit/hyperactivity disorder and the risk of acute seizures in individuals with epilepsy.
    Brikell I; Chen Q; Kuja-Halkola R; D'Onofrio BM; Wiggs KK; Lichtenstein P; Almqvist C; Quinn PD; Chang Z; Larsson H
    Epilepsia; 2019 Feb; 60(2):284-293. PubMed ID: 30682219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Med Wise: A theory-based program to improve older adults' communication with pharmacists about their medicines.
    Martin BA; Chewning BA; Margolis AR; Wilson DA; Renken J
    Res Social Adm Pharm; 2016; 12(4):569-77. PubMed ID: 26508269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
    Makus KG; McCormick J
    Clin Ther; 2007 Feb; 29(2):334-41. PubMed ID: 17472825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of medication appropriateness and clinical pharmacist drug therapy recommendations for home-based primary care veterans.
    Davis RG; Hepfinger CA; Sauer KA; Wilhardt MS
    Am J Geriatr Pharmacother; 2007 Mar; 5(1):40-7. PubMed ID: 17608246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach.
    Chung AY; Anand S; Wong IC; Tan KC; Wong CF; Chui WC; Chan EW
    Hong Kong Med J; 2017 Apr; 23(2):158-67. PubMed ID: 28302923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of consultant pharmacists in reducing medication problems among older adults receiving Medicaid waiver services.
    Alkema GE; Enguidanos SM; Wilber KH; Trufasiu M; Simmons WJ; Frey D
    Consult Pharm; 2009 Feb; 24(2):121-33. PubMed ID: 19275454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-related problems in the community setting: pharmacists' findings and recommendations for people with mental illnesses.
    Bell JS; Whitehead P; Aslani P; McLachlan AJ; Chen TF
    Clin Drug Investig; 2006; 26(7):415-25. PubMed ID: 17163274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
    Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
    Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.